Ministry of Food and Drug Safety

SEOUL – South Korea’s drug safety agency on Wednesday authorized the use of COVID-19 vaccine for children aged 5-11 for the first time amid the rapid spread of the Omicron variant. The two-dose vaccine, developed by Pfizer and BioNTech, was approved for use among minors aged 5 through 11, with a lower dose level of … Read more